Syngene International gets 5 USFDA observations for Bengaluru facilities Ruchika Sharma24 Feb 2025 11:30 AM ISTBengaluru: Syngene International has announced that the U.S. Food and Drugs Administration (USFDA) has concluded the inspection with five...
Syngene biologics manufacturing facility to be operational for US, European customers from mid year Ruchika Sharma18 March 2024 10:00 AM ISTBangalore: At DCAT 2024 global bio/pharmaceutical manufacturing forum, Syngene International, a global contract research, development and...
Syngene concludes acquisition of biologics manufacturing facility from Stelis Biopharma Ruchika Sharma4 Dec 2023 3:00 PM ISTBangalore: Syngene International has announced the conclusion of the acquisition of a multi-modal biologics manufacturing facility from Stelis...
Syngene International reports 14.22 percent increase in net profit at Rs 116.5 crore in Q2 Ruchika Sharma19 Oct 2023 1:30 PM ISTNew Delhi: Syngene International Ltd has reported a 14.22 per cent increase in consolidated net profit at Rs 116.5 crore in the September quarter.The...
Evaluate safety in proposed study: CDSCO Panel tells Syngene on Suplatast Tosilate Capsule Dr. Divya Colin7 Oct 2023 6:00 PM ISTNew Delhi: Approving the proposal presented by Syngene International to conduct a Phase II clinical trial of Suplatast Tosilate 100mg Capsule, the...
Syngene profit after tax rises 21 percent at Rs 179 crore in Q4 Ruchika Sharma28 April 2023 2:30 PM ISTRevenue from operations rose to Rs 3,193 crore in FY23 as compared with Rs 2,604 in 2021-22 fiscal.
Syngene announces expansion of biomanufacturing capacity Ruchika Sharma14 Aug 2021 11:00 AM ISTBengaluru: Syngene International, an integrated research, development and cGMP manufacturing services company, has announced the expansion of its...
Syngene appoints Alex Del Priore, Dr Alan Collis as new senior leaders in US Ruchika Sharma5 Aug 2021 11:00 AM ISTBengaluru: Syngene International has recently announced that the company has appointed two senior leaders, Alex Del Priore and Dr. Alan Collis, with...
